Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Palvella Therapeutics Inc (PVLA)

Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Palvella Therapeutics Inc 353 W. Lancaster Ave Suite 200 Wayne PA 19087 USA

https://palvellatx.com Employees: 14 P: 484-253-1461

Sector:

Medical

Description:

Palvella Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc., formerly known as Pieris Pharmaceuticals Inc., is based in WAYNE, Pa.

Key Statistics

Overview:

Market Capitalization, $K 970,670
Enterprise Value, $K 887,070
Shares Outstanding, K 11,836
Float, K 9,410
% Float 79.50%
Short Interest, K 1,354
Short Float 11.44%
Days to Cover 6.51
Short Volume Ratio 0.60
% of Insider Shareholders 20.50%
% of Institutional Shareholders 40.11%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -17,430 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -11,350 K
EBIT, $ -28,730 K
EBITDA, $ -26,830 K

Growth:

1-Year Return 417.82%
3-Year Return -40.40%
5-Year Return -65.13%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 82.52%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.03 on 11/11/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -2.63
EPS Growth vs. Prev Qtr -19.77%
EPS Growth vs. Prev Year 52.97%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-80 on 04/23/24

PVLA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -64.41%
Return-on-Assets % -42.75%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales -19,413.40
Price/Cash Flow N/A
Price/Book 22.85
Book Value/Share 3.50
Interest Coverage -3.03
60-Month Beta -0.16
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar